The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences

J Gastric Cancer. 2024 Jul;24(3):243-245. doi: 10.5230/jgc.2024.24.e26.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Chemotherapy, Adjuvant
  • Clinical Reasoning
  • Humans
  • Microsatellite Instability
  • Neoplasm Staging
  • Patient Preference*
  • Practice Guidelines as Topic
  • Stomach Neoplasms* / drug therapy
  • Stomach Neoplasms* / pathology